Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia. Owen C, Eisinga S, Banerji V, Johnson N, et al. Leuk Res 2023;133:107372.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Owen C, Eisinga S, Banerji V, Johnson N, et al. Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia. Leuk Res 2023;133:107372.
PMID: 37633157